Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
J Stenner
Observed names:
J. Stenner,
Jonathan M. C. Stenner,
Jonathan Stenner
Institution:
East Surrey Hospital
Observed institutions:
St George's Hospital,
St George's, University of London,
East Surrey Hospital,
Surrey and Sussex Healthcare NHS Trust
OpenAlex ID:
A5111690912
Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers
2002
·
Simon J. Moodie
, Liza Ang
, et al.
·
European Journal of Gastroenterology & Hepatology
·
16
PTU-104 Outcomes Of Increased Dose Of Allopurinol In Ibd Patients Who Developed Hepatotoxicity On Low Azathioprine And Allopurinol Co-therapy Treatment
2014
·
M Pericleous
, A Abdulrehman
, et al.
·
Gut
·
2
PDF
Effect of UDCA on Fibrosis Markers in Alcoholic Liver Disease
2000
·
J Stenner
, R Jazrawi
, et al.
·
Clinical Science
·
2
Su1374 Low Dose Azathioprine With Allopurinol Co-Therapy Without Metabolite Profiling Is More Effective and Safer Than Full Dose Azathioprine for Inflammatory Bowel Disease Patients: A Large UK Centre Experience
2014
·
Panagiotis Stamoulos
, Evangelos Stournaras
, et al.
·
Gastroenterology
·
1
PDF
Restricting HFE genotyping to patients with a transferrin saturation >60% is a cost effective screening strategy in liver clinic patients
2000
·
S. Moodie
, L. Ang
, et al.
·
Journal of Hepatology
·
1
PWE-129 Survey of Potential Blood Donors with Stable Haemochromatosis
2016
·
C Wong
, M Camarata
, et al.
·
Gut
OC-006 Safety And Efficacy Of Low Dose Azathioprine And Allopurinol Co-therapy: A Large Single Centre Experience
2014
·
P Stamoulos
, E Stournaras
, et al.
·
Gut
PDF
PTU-106 Successful Pregnancies With Thiopurine-allopurinol Co-therapy For Inflammatory Bowel Disease
2014
·
M Sheikh
, C Nelson-Piercy
, et al.
·
Gut
PDF
Su1389 Successful Pregnancies With Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease
2014
·
Mohammed Sheikh
, Catherine Nelson-Piercy
, et al.
·
Gastroenterology
Azathioprine/allopurinol co-therapy is an effective treatment for patients with inflammatory bowel disease who exhibit no response or side-effects to thiopurines without the need for metabolite level measurements
2011
·
P Stamoulos
, A Ansari
, et al.
·
Gut
PDF
Fibrosis markers and ursodeoxycholic acid
2000
·
J Stenner
, Riadh P. Jazrawi
, et al.
·
Research Repository (Kingston University London)
The distribution of haemochromatosis gene mutations within a multiracial south london population
2000
·
S. Moodie
, L. Ang
, et al.
·
Journal of Hepatology
Heterozygosity for HFE gene mutations and alcohol abuse are additive risk factors for biochemical iron overload
2000
·
S. Moodie
, L. Ang
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
13
Citation count:
22
H-index:
2
I10-index:
1
Year
Topic
Type
